Abraxane (Paclitaxel Protein-Bound)

Overview

Abraxane is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer after other treatments have failed. Abraxane may be also referred to by its drug name…

Ado-Trastuzumab Emtansine

Overview
Ado-trastuzumab emtansine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-trastuzumab emtansine may be… read more

Afinitor (Everolimus) for Breast Cancer

Afinitor (everolimus) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat postmenopausal women with advanced hormone…

Arimidex (Anastrozole)

Overview
Arimidex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in postmenopausal women in cases where the cancer is early-stage and hormone receptor-positive,… read more

Aromasin (Exemestane)

Overview
Aromasin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer after menopause. Aromasin is used as an adjuvant, or… read more

Beizray (Docetaxel) for Breast Cancer

Overview

Beizray is approved by the U.S. Food and Drug Administration (FDA) for the treatment of breast cancer. It is indicated as a single agent for locally advanced or metastatic breast cancer after failure of previous…

Datroway (Datopotamab Deruxtecan-Dlnk) for Breast Cancer

Datroway (datopotamab deruxtecan-dlnk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Ellence (Epirubicin hydrochloride)

Overview
Ellence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with axillary node tumor involvement after removal of primary breast cancer. Ellence may be also referred… read more

Enhertu (Fam-Trastuzumab Deruxtecan-Nxki) for Breast Cancer

Enhertu (fam-trastuzumab deruxtecan-nxki) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain…

Fareston (Toremifene)

The Fareston brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Fareston is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to…

Faslodex (Fulvestrant) for Breast Cancer

Faslodex (fulvestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with hormone receptor-positive…

Femara (Letrozole)

Overview
Femara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is used as an adjuvant, or post-surgical,… read more

Gemzar (Gemcitabine)

Overview
Gemzar is approved by the U.S. Food and Drug Administration (FDA) for use in combination with the chemotherapy drug paclitaxel as a first-line treatment for metastatic breast cancer in individuals who have not…

Halaven (Eribulin mesylate)

Overview
Halaven is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in adults who have previously received two chemotherapy regimens. Halaven may be also… read more

Herceptin (Trastuzumab) for Breast Cancer

What Members SayTop TipsSide EffectsCopay HelpFAQs

Herceptin (trastuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Herceptin Hylecta (Trastuzumab/Hyaluronidase-Oysk) for Breast Cancer

Herceptin Hylecta (trastuzumab/hyaluronidase-oysk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Hercessi (Trastuzumab-Strf) for Breast Cancer

Hercessi (trastuzumab-strf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Herzuma (Trastuzumab-Pkrb) for Breast Cancer

Herzuma (trastuzumab-pkrb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Ibrance (Palbociclib) for Breast Cancer

Ibrance (palbociclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with breast cancer.

Infugem (Gemcitabine)

Overview
Infugem is approved by the U.S. Food and Drug Administration (FDA) for use in combination with paclitaxel as a first-line treatment for metastatic breast cancer. It is specifically used when previous…

Inluriyo (Imlunestrant) for Breast Cancer

Inluriyo (imlunestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with certain types of metastatic breast cancer.

Itovebi (Inavolisib) for Breast Cancer

Itovebi (inavolisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with certain types of breast cancer.

Ixempra (Ixabepilone)

Overview
Ixempra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic or locally advanced breast cancer after at least two other therapies have not worked. Ixempra may be… read more

Kadcyla (Ado-Trastuzumab Emtansine) for Breast Cancer

Kadcyla (ado-trastuzumab emtansine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain HER2-positive breast…

Kanjinti (Trastuzumab-Anns) for Breast Cancer

Kanjinti (trastuzumab-anns) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Keytruda (Pembrolizumab) for Triple-Negative Breast Cancer

Keytruda (pembrolizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with triple-negative breast cancer.

Kisqali (Ribociclib) for Breast Cancer

Kisqali (ribociclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain hormone receptor-positive…

Lynparza (Olaparib) for Breast Cancer

Lynparza (olaparib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain inherited BRCA-mutated, HER2-negative breast cancer.

Margenza (Margetuximab-Cmkb) for Breast Cancer

Margenza (margetuximab-cmkb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic HER2-positive breast cancer.